Detalles de la búsqueda
1.
Leukoreduced PRP enhanced proliferation and ECM production yet inhibited senescence, inflammation, and multi-differentiation potential of AFSCs by downregulating HMGB1.
Immunopharmacol Immunotoxicol
; 45(6): 730-741, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37436160
2.
[Clinical comprehensive evaluation of Xiangju Capsules in treatment of rhinosinusitis].
Zhongguo Zhong Yao Za Zhi
; 48(15): 4243-4252, 2023 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-37802793
3.
[Systematic review and Meta-analysis of efficacy and safety of Binghuang Fule Ointment in treatment of eczema].
Zhongguo Zhong Yao Za Zhi
; 47(10): 2802-2810, 2022 May.
Artículo
en Zh
| MEDLINE | ID: mdl-35718500
4.
[Clinical comprehensive evaluation of Tianshu Capsules in treatment of migraine (syndrome of blood stasis blocking collaterals and syndrome of ascendant hyperactivity of liver Yang)].
Zhongguo Zhong Yao Za Zhi
; 47(6): 1501-1508, 2022 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-35347949
5.
[Pharmacovigilance of traditional Chinese medicine: an exploration based on prescription sequence analysis and prescription sequence symmetry analysis].
Zhongguo Zhong Yao Za Zhi
; 46(21): 5468-5474, 2021 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-34951198
6.
[Early detection and risk control of safety signals of Chinese medicine].
Zhongguo Zhong Yao Za Zhi
; 46(21): 5456-5461, 2021 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-34951196
7.
[Enlightenment of international pharmacovigilance system on establishment of pharmacovigilance system of Chinese medicine].
Zhongguo Zhong Yao Za Zhi
; 46(21): 5450-5455, 2021 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-34951195
8.
[Cognition of traditional Chinese medicine properties and thinking of clinical rational use of drug].
Zhongguo Zhong Yao Za Zhi
; 46(21): 5462-5467, 2021 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-34951197
9.
[Visualization of research on Chinese medicine-induced kidney injury by CiteSpace].
Zhongguo Zhong Yao Za Zhi
; 46(21): 5475-5485, 2021 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-34951199
10.
[Report standards for clinical comprehensive evaluation of Chinese patent medicine].
Zhongguo Zhong Yao Za Zhi
; 46(23): 6062-6067, 2021 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-34951233
11.
[Study on precise mechanism of Chinese patent medicine from perspective of activating data].
Zhongguo Zhong Yao Za Zhi
; 45(14): 3331-3335, 2020 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-32726047
12.
[Suggestions on design of evidence-based traditional Chinese medicine clinical study for new public health emergencies].
Zhongguo Zhong Yao Za Zhi
; 45(10): 2291-2295, 2020 May.
Artículo
en Zh
| MEDLINE | ID: mdl-32495582
13.
[Analysis of adverse reactions risk signal of Xinyuan Capsules based on national ADR monitoring spontaneous reporting system].
Zhongguo Zhong Yao Za Zhi
; 45(10): 2310-2315, 2020 May.
Artículo
en Zh
| MEDLINE | ID: mdl-32495586
14.
[ADR/AE early warning analysis of Shujin Jianyao Pills based on spontaneous reporting system].
Zhongguo Zhong Yao Za Zhi
; 45(15): 3533-3538, 2020 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-32893541
15.
[Randomized double-blind parallel controlled multicenter trial of Reyanning Mixture in treatment of acute tonsillitis].
Zhongguo Zhong Yao Za Zhi
; 45(14): 3282-3291, 2020 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-32726041
16.
Salvianolic Acids for Injection Combined with Conventional Treatment for Patients with Acute Cerebral Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Med Sci Monit
; 25: 7914-7927, 2019 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31639122
17.
[Systemic evaluation and Meta-analysis of efficacy and safety of Kangfu Xiaoyan Suppository in treatment of pelvic inflammatory disease].
Zhongguo Zhong Yao Za Zhi
; 44(22): 4962-4974, 2019 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-31872607
18.
[Systematic review and Meta-analysis of effect of Reduning Injection in treating acute tracheal-bronchitis].
Zhongguo Zhong Yao Za Zhi
; 44(24): 5294-5302, 2019 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-32237372
19.
[Analysis of Qingkailing Injection in treatment of combined medication features of 2 147 cases of upper respiratory tract infection].
Zhongguo Zhong Yao Za Zhi
; 44(23): 5207-5216, 2019 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-32237359
20.
[Expert consensus statement on Kangfu Xiaoyan Suppository in treatment of pelvic inflammatory in clinical practice].
Zhongguo Zhong Yao Za Zhi
; 44(20): 4350-4353, 2019 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-31872644